Medical tech LivaNova debuts on London Stock Exchange

3:40 AM ET Mon, 19 Oct 2015

André-Michel Ballester, CEO of LivaNova, which debuted on the stock market today, says his company is a leader in the treatment of cardiovascular diseases and epilepsy, and explains why the company decided to be headquartered in the U.K.